Morgan Stanley
NYSE:MS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
83.9
134.99
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Morgan Stanley
Current Assets | 178.9B |
Cash & Short-Term Investments | 90.2B |
Receivables | 88.7B |
Non-Current Assets | 1T |
Long-Term Investments | 756B |
Intangibles | 23.5B |
Other Non-Current Assets | 254.1B |
Current Liabilities | 642.8B |
Accounts Payable | 200.6B |
Accrued Liabilities | 5.3B |
Short-Term Debt | 431.6B |
Other Current Liabilities | 5.3B |
Non-Current Liabilities | 468.9B |
Long-Term Debt | 269.9B |
Other Non-Current Liabilities | 199B |
Balance Sheet
Morgan Stanley
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
21 381
|
19 827
|
22 017
|
46 164
|
51 840
|
49 659
|
105 654
|
127 725
|
128 127
|
89 232
|
|
Cash |
21 381
|
19 827
|
22 017
|
24 816
|
30 541
|
4 293
|
9 792
|
8 394
|
5 409
|
7 323
|
|
Cash Equivalents |
0
|
0
|
0
|
21 348
|
21 299
|
45 366
|
95 862
|
119 331
|
122 718
|
81 909
|
|
Total Receivables |
89 568
|
76 876
|
46 460
|
56 187
|
53 298
|
55 646
|
97 737
|
96 018
|
78 540
|
80 105
|
|
Total Current Assets |
110 949
|
96 703
|
68 477
|
102 351
|
105 138
|
105 305
|
203 391
|
223 743
|
206 667
|
169 337
|
|
PP&E Net |
6 108
|
6 373
|
0
|
0
|
0
|
3 998
|
4 419
|
4 268
|
4 073
|
4 368
|
|
PP&E Gross |
6 108
|
6 373
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accumulated Depreciation |
6 219
|
7 140
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Intangible Assets |
3 159
|
2 984
|
2 721
|
2 448
|
2 163
|
2 107
|
4 980
|
8 360
|
7 618
|
7 055
|
|
Goodwill |
6 588
|
6 584
|
6 577
|
6 597
|
6 688
|
7 143
|
11 635
|
16 833
|
16 652
|
16 707
|
|
Note Receivable |
66 577
|
85 759
|
94 248
|
104 126
|
115 579
|
130 637
|
150 597
|
188 134
|
213 785
|
218 640
|
|
Long-Term Investments |
539 677
|
540 181
|
562 432
|
557 162
|
546 225
|
599 971
|
725 927
|
729 793
|
710 454
|
755 627
|
|
Other Long-Term Assets |
0
|
0
|
0
|
34 231
|
35 356
|
32 512
|
0
|
0
|
0
|
0
|
|
Other Assets |
75 040
|
55 465
|
87 071
|
51 415
|
49 070
|
20 899
|
26 548
|
33 842
|
37 634
|
38 666
|
|
Total Assets |
801 510
N/A
|
787 465
-2%
|
814 949
+3%
|
851 733
+5%
|
853 531
+0%
|
895 429
+5%
|
1 115 862
+25%
|
1 188 140
+6%
|
1 180 231
-1%
|
1 193 693
+1%
|
|
Liabilities | |||||||||||
Accounts Payable |
181 069
|
186 626
|
190 513
|
191 510
|
179 559
|
197 834
|
225 318
|
226 521
|
211 861
|
203 788
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
4 778
|
7 446
|
7 321
|
9 174
|
9 777
|
|
Short-Term Debt |
230 973
|
214 257
|
227 276
|
229 452
|
249 487
|
253 062
|
369 100
|
422 061
|
434 859
|
429 512
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
22 969
|
3 691
|
5 764
|
4 191
|
3 188
|
|
Total Current Liabilities |
412 042
|
400 883
|
417 789
|
420 962
|
429 046
|
478 643
|
605 555
|
661 667
|
660 085
|
646 265
|
|
Long-Term Debt |
152 772
|
153 768
|
164 775
|
192 582
|
189 662
|
169 658
|
213 388
|
227 363
|
233 867
|
260 544
|
|
Minority Interest |
1 204
|
1 002
|
1 127
|
1 075
|
1 160
|
1 148
|
1 368
|
1 157
|
1 090
|
944
|
|
Other Liabilities |
164 592
|
156 630
|
155 208
|
159 723
|
153 417
|
164 431
|
193 770
|
192 512
|
185 048
|
186 902
|
|
Total Liabilities |
730 610
N/A
|
712 283
-3%
|
738 899
+4%
|
774 342
+5%
|
773 285
0%
|
813 880
+5%
|
1 014 081
+25%
|
1 082 699
+7%
|
1 080 090
0%
|
1 094 655
+1%
|
|
Equity | |||||||||||
Common Stock |
6 040
|
7 540
|
7 540
|
8 540
|
8 540
|
8 540
|
9 270
|
7 770
|
8 770
|
8 770
|
|
Retained Earnings |
44 625
|
49 204
|
53 679
|
57 577
|
64 175
|
70 589
|
78 694
|
89 432
|
94 862
|
97 996
|
|
Additional Paid In Capital |
24 249
|
24 153
|
23 271
|
23 545
|
23 794
|
23 935
|
25 546
|
28 841
|
29 339
|
29 832
|
|
Unrealized Security Profit/Loss |
73
|
319
|
474
|
547
|
930
|
207
|
1 787
|
245
|
4 192
|
3 094
|
|
Treasury Stock |
2 766
|
4 059
|
5 797
|
9 211
|
13 971
|
18 727
|
9 767
|
17 500
|
26 577
|
31 139
|
|
Other Equity |
1 175
|
1 337
|
2 169
|
2 513
|
1 362
|
2 995
|
3 749
|
3 347
|
2 061
|
3 327
|
|
Total Equity |
70 900
N/A
|
75 182
+6%
|
76 050
+1%
|
77 391
+2%
|
80 246
+4%
|
81 549
+2%
|
101 781
+25%
|
105 441
+4%
|
100 141
-5%
|
99 038
-1%
|
|
Total Liabilities & Equity |
801 510
N/A
|
787 465
-2%
|
814 949
+3%
|
851 733
+5%
|
853 531
+0%
|
895 429
+5%
|
1 115 862
+25%
|
1 188 140
+6%
|
1 180 231
-1%
|
1 193 693
+1%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
1 951
|
1 920
|
1 852
|
1 788
|
1 700
|
1 594
|
1 810
|
1 772
|
1 675
|
1 627
|
|
Preferred Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|